Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation. uri icon

authors

  • Julio A. Chirinos, MD, PhD
  • Ahn, Yeon S
  • Castrellon, Aurelio
  • Zambrano, Juan Pablo
  • Jimenez, Joaquin J
  • Jy, Wenche
  • Horstman, Lawrence L
  • Willens, Howard J
  • Castellanos, Agustin
  • Myerburg, Robert J

publication date

  • May 2005